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Background: CBX7 is a Polycomb group protein that shows variable expression changes in various cancers that are
often contradictive. A mouse knockout experiment has validated the tumor suppressor role in carcinogenesis. The
purpose of this study is to verify the tumor suppressor role of Cbx7 in human colon carcinomas (CC).
Methods: Frozen CC and the surgical margin (SM) tissue samples from patients (n = 97) were obtained from the
Peking University Cancer Hospital. All patients had follow-up data for at least three years. The level of Cbx7 mRNA
and protein was determined by quantitative RT-PCR, immunohistochemistry and Western blot, respectively. The
association between Cbx7 mRNA level and clinicopathological characteristics of CC patients was then statistically
analyzed.
Results: CBX7 expression changes detected through immunohistochemistry and Western blot in 10 pairs of
representative CC samples significantly correlated with their corresponding mRNA levels when Alu, but not GAPDH,
was used as the endogenous reference control in quantitative RT-PCR. The Alu-normalized Cbx7 mRNA levels were
significantly increased in SM tissues when compared with CC tissues or colon biopsies taken from non-cancer
patients (Student’s t-test, P < 0.036 or 0.007). Furthermore, decreased levels of Cbx7 mRNA positively correlated with
lymph metastasis (P = 0.029). Overall survival (OS) of CC patients classified as Cbx7 expression-low was considerably
shorter than those classified as Cbx7 expression-high (Hazard ratio = 2.97, 95% CI [1.68 ~ 5.25]; P <0.001). Multiple
variant analyses showed that the Cbx7 expression-low was an independent predictor of short OS (Hazard ratio = 3.16,
95% CI [1.58-6.30]; P < 0.001).
Conclusion: Cbx7 is downregulated in CCs, and Cbx7 expression-low tumors correlated with lymph metastasis and
poor overall survival of CC patients.
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The Polycomb-group (PcG) proteins function as epigenetic
transcriptional regulators through multiple mechanisms.
PcG proteins are mainly categorized into two groups,
polycomb repressive complex 1 (PRC1) and 2 (PRC2) [1].
CBX7 is a Polycomb protein that has shown tumor sup-
pressive function and is a component of PRC1. Recent* Correspondence: dengdajun@bjmu.edu.cn
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unless otherwise stated.studies have utilized cbx7-knockout mice to validate the
tumor suppressor role of cbx7 in liver and lung carcino-
genesis [2]. However, analysis of many types of cancers re-
vealed that the Cbx7 expression levels were significantly
altered, but the changes were often considerably contradic-
tive. While some studies showed that Cbx7 behaved as an
oncogene in lymphoma, prostate cancer, ovarian cancer,
and gastric cancer [3-6], other studies indicated Cbx7 was
acting as a tumor suppressor gene in the bladder, colon,
pancreas, and thyroid cancers [7-11]. Currently, the rea-
sons leading to these conflicting results have not been
investigated.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and the fourth leading cause of cancer death worldwide
[12]. One large-scale patient study indicated that the loss
of Cbx7 expression in CC correlates with poor prognosis
and short survival using results analyzed through immu-
nohistochemistry in tissue microarray [11]. Using quanti-
tative RT-PCR (qRT-PCR), similar results were obtained
among 22 Chinese CC patients [13]. The qRT-PCR assay
offers significant advantages over the hemi-quantitative
immunohistochemistry assays for detecting Cbx7 expres-
sion changes in cancers. In the present study, a qRT-PCR
assay capable of correlating Cbx7 mRNA level with pro-
tein expression was developed, and the Cbx7 transcription
levels from 97 CC patients were quantified and statistically
analyzed for clinicopathological correlations.
Methods
Clinical samples
CC and surgical margin (SM) tissue specimens were ob-
tained from surgical resection patients without neo-
adjuvant therapy (n = 97) in Peking University Cancer
























aAlu-normalized relative copy number (×10−4), the value is presented median (25%population contained 49 males and 48 females with a
mean age of 62 years (range 34–89), who were not in-
cluded in the previous study [13]. Tumors were staged
using the tumor-node-metastasis (pTNM) staging of the
International Union Against Cancer (2003) [14]. The
number of patients staged from I to IV were 1, 33, 36
and 27, respectively (Table 1). The SM tissues were more
than 5 cm from the tumor and were validated by an ex-
perienced pathologist. None of the patients received pre-
operative chemotherapy. All patients had follow-up data
for at least 36 months (median 61). 49 CC patients were
post-operatively treated with adjuvant chemotherapy
(Folfox for 30 patient). 45 patients (46.4%) suffered recur-
rent CC and 52 patients (53.6%) died during follow-up.
Paraffin blocks were selected from suitable formalin-
fixed paraffin-embedded tissue with an average age of
62.2 years (range 34 ~ 89). Normal colon biopsies were
obtained from non-cancerous patients (n = 51). The In-
stitutional Review Boards of Peking University Cancer
Hospital and Institute approved the study. All samples
were obtained with the patients’ informed written
consent.cal features of colon cancer patients
n Cbx7 mRNA levela
Colon cancer Surgical margin
42 2.69 (1.07-4.61)b 2.42 (1.31-4.88)
55 1.38 (0.44-3.37) 1.72 (0.98-4.43)
49 2.04 (0.74-4.54) 1.77 (0.97-4.00)
48 1.60 (0.90-3.40) 2.22 (1.31-5.29)
42 1.94 (1.05-4.52) 1.70 (1.27-3.27)
37 1.90 (0.72-4.61) 1.94 (1.04-6.26)
18 1.29 (0.61-2.75) 2.42 (1.20-7.74)
24 1.60 (0.89-3.59) 1.60 (1.31-3.54)
70 2.02 (0.76-4.59) 2.22 (0.949-6.05)
69 1.95 (0.79-4.48) 1.94 (1.27-5.25)
26 1.74 (0.69-4.13) 1.90 (1.13-4.71)
39 2.06 (1.01-4.54) 1.94 (0.66-5.41)
58 1.63 (0.69-3.92) 1.90 (1.30-4.66)
5 5.77 (4.48-8.25) 1.31 (0.30-3.09)
51 1.40 (0.38-3.73) 2.39 (0.94-5.83)
41 1.83 (0.96-3.81) 1.82 (1.31-3.39)
50 2.54 (1.07-4.57)b 1.77 (1.18-4.63)
47 1.29 (0.24-2.94) 2.22 (1.12-4.85)
69 2.04 (0.96-4.27) 1.94 (1.08-4.95)
29 1.31 (0.42-4.56) 1.97 (1.22-5.15)
48 1.93 (0.75-3.77) 1.75 (1.03-5.03)
49 1.64 (0.94-4.48) 2.22 (1.27-4.00)
~ 75% percentile); bMann–Whitney test, P = 0.007
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Total RNA was extracted from 30–50 mg of tumor tissue
using a commercial RNA isolation kit according to the
manufacturer’s protocol (Ultrapure RNA Kit, CWBIO,
Beijing). Subsequently, the RNA concentration was checked
using 1.0% agarose gel electrophoresis stained with
0.5 μg/ml ethidium bromide and quantified with a
NanoVue spectrophotometer (GE Healthcare). For reverse
transcription, 1 μg RNA, 20 units reverse transcriptase, 1×
reaction buffer, 1 mM deoxynucleotides, 3 mM MgCl2,
and 4.0 mg of random hexamers were used. The reaction
mixtures were incubated at 25°C for 10 min, 42°C for 1 h,
and 95°C for 5 min according to the manufacturer’s pro-
tocol (Improm-II Reverse Transcription System A3800,
Promega, USA). The cDNA was stored at −20°C.
qRT-PCR was performed using an ABI 7500 Fast
Realtime System (Applied Biosystems, Foster City, CA,
USA). Primers and a TaqMan probe for Cbx7 were de-
signed and synthesized according to the Taqman Gene
Expression Assay (Roche Diagnostics, Mannheim, German).
The primer sequences follow: human Cbx7 gene 5′-
cgtcatggcctacgagga-3′ (sense), 5′-tgggtttcggacctctctt-3′
(antisense); TaqMan probe 5′-FAM-aggaggag-TEMER-
3′ [8,15]; GAPDH 5′-gaaggtgaaggtcggagt-3′ (sense) and
5′-gaagatggtgatgggatttc-3′ (antisense); the Alu elements
5′-gaggctgaggcaggagaatcg-3′ (sense), 5′- gtcgcccaggctgg
agtg-3′ (antisense) [16]. PCR reactions were carried out in a
final volume of 10 μL containing 5 μL Maxima Probe/ROX
qPCR Master Mix (2×) (K0233, Thermo Scientific), 0.5 μM
of each primer and DNase-free water. The PCR conditions
were 5 min at 95°C, followed by 40 cycles of 95°C for 15 s,
54°C for 30s, and 72°C for 35 s and finished with a melting
curve analysis. The relative copy number [2-ΔCT] of Cbx7
mRNA was determined from the difference in cycle thresh-
old (CT) values between the target and reference genes.
Immunohistochemistry (IHC)
The paraffin was removed from the embedded CC and SM
tissue samples using xylene. The samples were then rehy-
drated in a graded series of ethanol solutions. Antigen re-
trieval was performed in Tris/EDTA (pH 9.0) for 3 min at
120°C. The sections were then incubated for 20 min in 3%
H2O2 and washed with 0.025% Triton X-100/TBS (TBST).
Blockage was performed with 10% goat serum for 2 h
at room temperature. The slides were then incubated
overnight at 4°C with anti-CBX7 monoclonal antibody
(ab21873, Abcam, Cambridge, UK). Subsequently, the sec-
tions were incubated with an HRP-conjugated anti-mouse
EnVision system (DAKO, Glostrup, Denmark) for 20 min
at 37°C followed by staining with diaminobenzidine hydro-
chloride (DAB, DAKO). Normal mouse IgG was applied as
negative control (Additional file 1: Figure S1). The sections
were counterstained with hematoxylin. The intensity of
nuclear CBX7-staining in the epithelial and stromal cellswas grouped as negative (−), weak (visible at high magnifi-
cation = +1), moderate (visible at low magnification = +2),
or strong (strikingly positive at low magnification = +3).
Western blot
Whole-cell protein extracts were prepared from primary tu-
mors. The samples underwent electrophoresis in a 12% SDS-
PAGE gel followed by blotting onto a Polyvinylidene-Fluoride
membrane (Bio-Rad). The membranes were incubated in PBS
containing 5% skim milk and 0.05% Tween-20 for 2 h at
room temperature, then probed overnight with anti-CBX7
antibody (1:1000) (Abcam) in blocking solution at 4°C. An
HRP-labeled goat anti-rabbit secondary antibody was then
used (DAKO K5007, Glostrup, Denmark). The results were
visualized on a Fluor chem system (Cell Biosciences). Inte-
grated Option Density (IOD) was used to quantify the
amounts of CBX7 and β-Actin. β-Actin was used as a refer-
ence control. In order to normalize the levels of CBX7 be-
tween samples, the IODCBX7/IODReference ratio was calculated.
Cbx7 plasmid construction and transfection
The coding region of Cbx7 was inserted into the pEGFP-
C1 vector and used to transfect cultured cells as described
previously [15].
Transwell migration and matrigel invasion assays
The migration and invasion capacity of colon cancer cell
lines SW480 (5 × 104 cells/well) and HCT116 (4 × 104
cells/well) (kindly provided by Dr. Yuanjia Chen at
Peking Union Medical College Hospital) were tested
using the Transwell migration and invasion assays 48 hrs
after transiently transfection with the Cbx7 plasmid or
empty vectors for 48 hrs. [15].
Formation of pulmonary tumor in nude mice
SW480 cells (2 × 106 cells in 0.2 ml) were injected into
SCID mice via the tail vein 48 hrs after transient trans-
fection with the Cbx7 plasmid or empty vectors. The
mice (8/Group) were harvested during the 6th experi-
mental week. Chest wall, number of pulmonary metasta-
sis tumor nodules, and the lung weight were then
measured for each mouse. The lung organs were fixed
with Bouin solution, paraffin-embedded and cut into
5 μm slides along the maximum area, and examined
microscopically following H.E. staining.
Statistical analysis
All statistical analyses were performed using SPSS soft-
ware (SPSS version 17.0). The correlation between CBX7
protein level and mRNA level was analyzed using the
Spearman’s rank correlation coefficient or the Pearson
product–moment correlation coefficient. The nonpara-
metric Wilcoxon test, Kruskal-Wallis test, and Mann–
Whitney test were applied to evaluate the association
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features. Kaplan–Meier survival curves were generated
and compared using the log-rank test. A multivariable Cox
regression model was applied to determine if a particular
factor was an independent predictor of survival in mul-
tivariate analysis. All statistical tests were two-sided, and
P-values < 0.05 were considered statistically significant.
Results
qRT-PCR optimization for quantifying Cbx7 mRNA levels
in colon tissues
GAPDH mRNA is traditionally used as the reference
control in qRT-PCR; however, the transcription of AluFigure 1 Correlation analysis between CBX7 expression in immunohis
reference genes. (A) CBX7-IHC images for CC and SM samples from three
cancer cells (red-arrows) in the representative colon cancer (CC) tissues, but lo
in the corresponding surgical margin (SM). (B) CBX7-IHC staining scores and G
Alu-normalized Cbx7 mRNA levels. The relative copy number of Cbx7 mRNA w
target and reference genes.elements is a novel reference control that has recently
been developed to replace GAPDH [16]. In order to
identify the optimal reference control for our study,
qRT-PCR was run using both the Alu and GAPDH refer-
ence controls to determine the correlation between
CBX7 protein levels (used as the golden standard) and
Cbx7 mRNA levels in the same set of human colon tis-
sues. The amount of CBX7 protein in the paired CC and
SM samples (n = 10) was analyzed using the IHC assay.
Results of IHC analysis revealed diverse patterns of
CBX7 expression changes in CC relative to the corre-
sponding SM samples. While CBX7 expression was de-
creased in some CC samples (Figure 1 No.2), it wastochemical (IHC) analysis and quantitative RT-PCR using different
patients; Strong nuclear CBX7 protein staining was mainly located in
cated in both glandular epithelial cells and lymphoid cells (blue-arrows)
APDH-normalized Cbx7 mRNA levels; (C) CBX7-IHC staining scores and
as determined from the difference in cycle threshold values between the
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ples (Figure 1 No.5). In addition, the CC tissues revealed
strong CBX7 protein expression in the nucleus of cancer
cells. However, nuclear CBX7 staining was more preva-
lent in the glandular epithelial cells and stromal lymph-
oid cells in the corresponding SMs (Figure 1) as well as
normal colon biopsies from non-cancer patient controls
(Additional file 1: Figure S1).
Consistent with our previous study [13], the amount
of Cbx7 mRNA in the 10 pairs of CC tissues was signifi-
cantly lower than the SM tissues when GAPDH was
used as the reference in qRT-PCR analysis (P = 0.013);
however, the GAPDH-normalized Cbx7 mRNA level was
not correlated with the amount of CBX7 protein de-
tected in the IHC assay (Spearman’s rank correlation co-
efficient, rs = +0.204, P = 0.460; Figure 1B). In contrast,
when Alu was used as the reference control the CC and
SM samples did not show a significant difference in
Cbx7 mRNA levels (P = 0.939); however, the Cbx7
mRNA levels strongly correlated with the amount of
CBX7 protein (Spearman's rank correlation coefficient,
rs = +0.763, P < 0.001; Figure 1C).
In order to verify the IHC results, Western blot was
performed on the CC and SM samples to validate the
CBX7 protein levels. The results were consistent with
IHC (Figure 2A). The positive correlation between
CBX7 protein level and mRNA level in the Alu control
samples was confirmed (Pearson product–moment correl-
ation coefficient, rp = +0.670, P = 0.001), and no correlation
was seen in the GAPDH control samples (rp = +0.366,Figure 2 Correlation analysis between CBX7 expression in Western bl
genes. (A) Detection of CBX7 protein in CC and SM samples using Wester
GAPDH-normalized Cbx7 mRNA levels; (C) Relative intensities of CBX7 proteP = 0.113) (Figure 2B, C). Therefore, the Alu transcript
was used for qRT-PCR analysis.
In order to investigate whether there was a significant
difference in Cbx7 transcription between CC and SM
tissues, a larger sample size of patients (n = 97) was ana-
lyzed. Results showed that the average level of Cbx7
mRNA was significantly lower in CC tissues than SM
tissues (ΔCT value: 13.0 vs. 12.3; Student’s t-test, P =
0.036; Figure 3). However, the Cbx7 mRNA level in SM
tissue was also significantly higher than normal colon
tissue controls (n = 51) (ΔCT value: 12.3 vs. 13.5; P <
0.007, Figure 3). Taken together, the relative copy num-
bers of Cbx7 mRNA in the SMs and CCs are 245% and
151% of that in the normal controls, respectively. These
results suggest that Cbx7 transcription is considerably
upregulated in the SMs.
Downregulation of Cbx7 expression correlated with poor
prognosis of CC patients
Association analysis showed that CC patients with
lymph metastasis had lower Cbx7 mRNA levels than
their negative counterparts (Table 1; P = 0.029). Further-
more, younger patients (cutoff age, 62 years old) dis-
played significantly higher Cbx7 mRNA expression levels
than older patients (P = 0.027). Significant associations
were not observed between patients with different gen-
der, tumor differentiation, vascular invasion states, inva-
sion, distant metastasis, or pTNM stage. In addition, the
Cbx7 mRNA levels in the SM samples were not associ-
ated with clinicopathological features.ot analysis and quantitative RT-PCR using different reference
n blot analysis; (B) Relative intensities of CBX7 protein to β-Actin and
in to β-Actin and Alu-normalized Cbx7 mRNA levels.
Figure 3 Comparison of Cbx7 mRNA levels among Normal, CC
and SM samples. The mRNA level represented as the ΔCT value
between Alu and Cbx7 transcripts. A higher ΔCT value indicates a
lower mRNA level.
Zheng et al. BMC Cancer  (2015) 15:145 Page 6 of 10Using the Cbx7 mRNA level in CC tissues to detect me-
tastasis, the integral (AUC) of the receiver operating char-
acteristic (ROC) curve was 62.9% (Figure 4A; P = 0.029).
By using the relative copy number of 7.45 × 10−5 as the
cut-off value, patients classified as Cbx7 mRNA-low had a
shorter overall survival (OS) than patients classified as
Cbx7 mRNA-high (hazard ratio = 2.97; 95% CI [1.68 ~
5.25]; P < 0.001) (Figure 4B). The three-year survival rates
were 20.8% (5/24) and 54.8% (40/73) for the Cbx7 mRNA-
low and -high patients, respectively. Multivariable analysis
revealed that Cbx7mRNA level was an independent factor
for OS after adjusting for vascular invasion, pTNM stage,
age, sex, and differentiation (hazard ratio = 3.16, 95% CI
[1.58-6.30], P <0.001; Table 2).
Effects of enforced Cbx7 overexpression on migration and
invasion of cancer cells
The Transwell migration and Matrigel invasion assays
were further used to study whether CBX7 directly affectsFigure 4 Cbx7 mRNA level in CCs correlates with prognosis. (A) ROC c
(cut-off value = 7.45 × 10−5); the area under the curve (AUC) is 62.9% (P < 0.
Cbx7 expression-low and –high (P = 0.001, log-rank test).metastasis of cancer cells transient transfected with the
Cbx7 expression vector (Additional file 2: Figure S2). Re-
sults showed that transient Cbx7 overexpression signifi-
cantly increased migration and invasion of colon cancer
HCT116 cells (Figure 5A, B). Similar results were also
observed in another colon cancer cell line SW480
(Figure 5C, D). Proliferation of these cells was not affected
by Cbx7 overexpression (data not shown).
In order to further elucidate the effect of CBX7 on
cancer cell migration, SW480 cells transiently trans-
fected with the Cbx7 or control vector were injected into
the tail vein of SCID mice, and the pulmonary metasta-
ses were subsequently analyzed (Figure 6). Six weeks
after injection, the average lung weight of the mice in
the CBX7 group (n = 8; 0.395 g ± 0.022) was similar with
that in the vector control group (n = 8; 0.387 g ± 0.023).
The positive rate of pulmonary metastasis in the CBX7
group (3/8) was slightly increased compared to the control
group (1/8), but not statistically significant (Fisher-exact
test, P = 0.57). Additionally, 3 pulmonary nodules were
identified in the CBX7 group, compared to 2 in the con-
trol group. However, this difference was not significant.
Discussion
The Cbx7 expression levels in human cancers are
highly variable and often contradictive. The organ/tissue-
specificity, assay used for analysis, and sample differences
may account for these conflicting results. In the present
study, it was determined that by using Alu as the
normalization control, Cbx7 mRNA levels in the CC and
SM tissues were positively and significantly correlated
with the amount of CBX7 protein detected by both IHC
and Western blot. Such a correlation was not observed
when GAPDH was used as the normalization control. By
using the Alu RNA reference, it was found that Cbx7
transcription was significantly downregulated in CC andurve of CC metastasis used to classify patients as Cbx7-high or low
029); (B) Kaplan-Meier overall survival curves for patients classified as
Figure 5 Enforced Cbx7 overexpression promotes migration of colon
Matrigel invasion tests using HCT116 cells transiently transfected with the C
Transwell migration and Matrigel invasion tests using SW480 cells transient
The transfection efficiency is presented in Figure S2.
Table 2 Multivariate analysis of overall survival in colon
cancer patients
Variable Hazard ratio (95% CI) P-value
Cbx7 mRNA-low 3.16 (1.58-6.30) 0.001
Vascular invasion 3.43 (1.64-7.17) 0.001
pTNM 4.13 (1.71-9.98) 0.002
Age 1.31 (0.65-2.64) 0.449
Sex 0.70 (0.38-1.29) 0.255
Differentiation 0.79 (0.39-1.61) 0.512
Adjuvant therapy 1.05 (0.55-2.01) 0.888
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lymph metastasis and poor overall survival in Chinese CC
patients. These results are consistent with a previous re-
port, which showed that loss of CBX7 expression in CC
correlates with poor outcomes based on large-scale pa-
tient analysis by IHC in tissue microarray [11].
GAPDH is the traditional reference used in qRT-PCR
to normalize mRNA levels in cell/ tissue samples con-
taining different cell numbers. It is especially effective
for samples of homogeneous cellularity/constitution;
however, its reliability for normalization in samples that
are cellularly heterogenic is problematic. This shortcom-
ing is especially highlighted when attempting to compare
gene mRNA levels in cancer tissues with correspondingcancer cell lines. (A and B) Results of Transwell migration and
bx7 expression vector for 48 hrs, respectively; (C and D) Results of
ly transfected with the Cbx7 expression vector for 48 hrs, respectively.
Figure 6 Images of experimental pulmonary metastasis nodules of colon cancer SW480 cells with or without Cbx7 overexpression in
SCID mice. Slides are prepared along the maximum lung area for each mouse.
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posed for proper data normalization in qRT-PCR [16-18].
There are about 800,000 copies of Alu elements in each
haploid of the human genome. More than one million
copies of the Alu element (about 300 bp) are located in
untranslated regions (UTRs) of 1,500 genes. Therefore,
transcriptional dysregulation of a few Alu elements has no
significant affect on altering the total amount of Alu tran-
scripts in the whole human transcriptome. This unique
characteristic makes Alu transcripts a good reference gene
for qRT-PCR. It is known that Alu elements are globally
hypomethylated in cancers [19]; however, it is not known
if the hypomethylation leads to upregulation of Alu ex-
pression in the genome and subsequently decreases its re-
liability. The high consistency between CBX7 protein level
and Alu-normalized Cbx7 mRNA level in colon tissues
found in the present study is in strong agreement with re-
cent reports suggesting that Alu RNA is a reliable refer-
ence in qRT-PCR analysis [16], and could be particularly
beneficial for the evaluation of gene expression changes
between cancer and normal tissues.
It has been reported that Cbx7 transcription was
downregulated among 22 Chinese CC patients using the
typical GAPDH-normalized qRT-PCR analysis [13]. Al-
though a similar result was also observed among the 10
pairs of CC and SM samples in the present study, the
GAPDH-normalized Cbx7 mRNA levels did not correl-
ate with the amount of CBX7 protein detected throughIHC and Western blot analysis. This implies that the ob-
served difference in GAPDH-normalized Cbx7 mRNA
levels between CC and SM samples may not be an ac-
curate indicator of protein level. Although other factors,
such as stability and degradation differences, could have
played a role in the inconsistency observed between
mRNA and protein levels of a gene in tissues of interest,
the high consistency and repeatability seen using the
Alu-normalized Cbx7 mRNA and CBX7 protein levels
shows that selecting a suitable reference is very critical in
drawing a reliable conclusion. Use of an unreliable refer-
ence gene for qRT-PCR analysis may contribute more to
the noted inconsistency than has previously been esti-
mated. It is increasingly necessary to determine if the cor-
rect normalization control is being used when qRT-PCR
assays are utilized in studies on tumor biology [20,21].
Interestingly, although the average Cbx7 mRNA level
in SMs was significantly higher than CCs, it was also sig-
nificantly higher than in normal colon control tissues
from non-cancer patients. Age also seems to be associ-
ated with the levels of CBX7. The average level of Cbx7
mRNA in CC and SM samples from patients ≤62 yrs
was significantly higher than was observed in older pa-
tients. Therefore, because the CC patients were much
older than the controls, the Cbx7 mRNA level in the
normal colon tissues distant from the site of malignancy
(not available in the present study) should be lower than
that from the non-cancer controls. In other words, the
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and distant normal colon from the CC patients might be
higher than the observed difference between the SMs
and normal colon biopsies from non-cancer patients.
This suggests that alteration of Cbx7 expression in colon
carcinogenesis may be far more complex than expected.
According to the map of human proteome [22],
CBX7 is highly expressed in B cells (Additional file 3:
Figure S3). In the present study, strong nuclear CBX7
staining was frequently observed in the lymphoid cells
in the SMs and the normal colon biopsies, but not in
CC samples. It is likely that both the decreased number
of CBX7-positive lymphoid cells in the CC tissues, and
the increased number of lymphocytes infiltrating into
stromal tissues around cancer cells contributes to the
downregulation of Cbx7 expression in CCs. It cannot
be excluded that Cbx7 may be upregulated in SMs as a
B-cell infiltration-related host response to the presence
of cancer cells. More studies are necessary to further
elucidate the role of Cbx7 in tumor development and
modulation.
Contribution of CBX7 to cancer development may be
organ-dependent [3-11]. CBX7 is suggested to help sup-
press the progression of human colon cancers [10,13].
The results of our study were in close agreement with
this conclusion. However, the results of the Transwell
tests and mouse experimental pulmonary metastasis
assay showed that enforced Cbx7 overexpression might
slightly increase the migration/invasion capacity of colon
cancer cells. This suggests that the role of the exogenous
Cbx7 overexpression in epithelial cancer cells might be
different from that of the endogenous Cbx7 in colon
cancer. Whether downregulation of Cbx7 in stromal
lymphoid cells involves in the progression of colon can-
cers should be studied further.Conclusions
In conclusion, this study revealed that the total amount
of Alu RNA is a suitable and accurate endogenous refer-
ence for qRT-PCR analysis. Most importantly, it was
shown that Cbx7 is downregulated in CC and Cbx7
expression-low is associated with metastasis and short
overall survival of CC patients.Additional files
Additional file 1: Figure S1. IHC analysis of CBX7 expression in normal
colon biopsies from non-cancer patients. Strong nuclear CBX7 protein
staining was located in both glandular epithelial cells (red arrows) and
lymphoid cells (blue arrows) in the normal colon tissues. Bar, 100 μm.
Additional file 2: Figure S2. Transfection efficiency of CBX7 EGFP-C1
vector in cancer cell lines HCT116 and SW480. Both cytoplasm and
nucleus EGFP proteins are observed in most cells at 48 hrs following
transient transfection with the EGFP control vector (GFP-Ctrl). EGFP-CBX7fusion proteins mainly locate in the nucleus of cells at 48 hrs following
transfection with the EGFP-CBX7 vector (GFP-CBX7).
Additional file 3: Figure S3. CBX7 protein level in various human tissues
and cells analyzed using high-resolution Fourier-transform mass spectrometry.
This map has been downloaded from the Human Proteome Map Web site
(http://www.humanproteomemap.org) (Ref: [22]).
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